Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uveal Melanoma × sargramostim × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

Nivolumab 5 Cyclophosphamide 4 pembrolizumab 3 tebentafusp 2 fludarabine phosphate 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 ulixertinib 1 trametinib 1 relatlimab 1 omipalisib 1 olaparib 1 fludarabine 1 cemiplimab 1 binimetinib 1 Watchful Waiting 1 Vorinostat 1 Valproic Acid 1 TYRP1 protein, human 1 Sunitinib 1 Spinal Puncture 1 Radiosurgery 1 Protein Kinase C 1 Practice Guidelines as Topic 1 Methods 1 LY2940680 1 Interleukin-2 1 Interleukin-13 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡